Skip to main content

Advertisement

Table 1 Demographic and clinical data for the in vivo therapeutic efficacy study (A) and the in vitro drug assay (B)

From: Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India

A. In vivo therapeutic efficacy study B. In vitro drug assay
Characteristics (N = 125) Characteristics   (N = 96)
Sex [n (%)] Male 120 (95.0) Sex [n (%)] Male 85 (88.5)
  Female 5 (5.0)   Female 11 (11.5)
Wt (kg)    Age (yr)   
  Mean 52.8   Mean 23.9
  Range 5.0-77.0   Range 7-53
  SD ±10.4   SD 8.3
  95% CI 51.0-54.7   95% CI 22.2-25.6
Age (yr) Parasite count (n/μl)  
  Mean 25.9   Mean 6348.6
  Range 13-66   Range 480-21,522
  SD 10.5   SD 4390.8
  95% CI 24.0-27.8   95% CI 5,172.8-7,524.5
Body temperature (°F)   Parasitaemia (%)  
  Mean 98.5   Mean 0.163
  Range 95.4-104.4   Range 0.032-0.445
  SD 2.2   SD 0.094
  95% CI 98.1-98.9   95% CI 0.122-0.203
Haemoglobin (g/dl)   Rings (%)  
  Mean 14.4   Mean 3.2
  Range 12.0-16.6   Range 0.0-33.3
  SD 1.0   SD 5.9
  95% CI 14.2-14.6   95% CI 1.9-4.6
Parasite count (n/μl)   Trophozoites (%)  
  Mean 9049.2   Mean 91.0
  Range 1,000-57,200   Range 58.3-100.0
  SD 6697.3   SD 11.6
  95% CI 5,243.4-7,624.4   95% CI 88.4-93.6
    Schizonts (%)   
     Mean 5.8
     Range 0.0-33.3
     SD 1.1
     95% CI 3.6-7.9